TARRYTOWN, N.Y., Nov. 21, 2016 /PRNewswire/
-- Regeneron Pharmaceuticals, Inc. (NASDAQ:
REGN) today announced that Leonard
Schleifer, M.D., Ph.D., Founder, President and Chief
Executive Officer, and George
Yancopoulos, M.D., Ph.D., Founding Scientist, President of
Regeneron Laboratories and Chief Scientific Officer, have been
named the EY (Ernst & Young) Entrepreneurs Of The
Year® 2016 National Award Winners in the Life Sciences
category.
The EY Entrepreneur Of The Year Award, a leading business award
for entrepreneurs, recognizes leaders and visionaries who
demonstrate innovation, financial success and personal commitment
as they create and build world-class businesses. A panel of
independent judges selected Drs. Schleifer and Yancopoulos from
more than 250 regional award recipients.
"Under Len and George's leadership, Regeneron has grown from a
tiny start-up into a leading biotechnology company," said
P. Roy Vagelos, M.D., Chairman of
the Regeneron Board of Directors. "Even now, as the company has
grown to over 5,000 employees, Len and George continue to lead with
a fierce entrepreneurial spirit and a willingness to do things
differently. This spirit has enabled the Regeneron team to bring
important medicines to people in need and to advance a promising
pipeline of therapies for serious diseases."
To view the full list of this year's winners, please visit:
http://www.ey.com/us/en/about-us/entrepreneurship/entrepreneur-of-the-year.
About Regeneron Pharmaceuticals, Inc.
Regeneron
(NASDAQ: REGN) is a leading science-based biopharmaceutical company
that discovers, invents, develops, manufactures and commercializes
medicines for the treatment of serious medical conditions.
Regeneron commercializes medicines for eye diseases, high LDL
cholesterol and a rare inflammatory condition and has product
candidates in development in other areas of high unmet medical
need, including rheumatoid arthritis, atopic dermatitis, asthma,
pain, cancer and infectious diseases. For additional information
about the company, please visit www.regeneron.com or follow
@Regeneron on Twitter.
About EY Entrepreneur Of The Year™
The EY Entrepreneur
Of The Year is the world's most prestigious business award for
entrepreneurs. The program makes a difference through the way it
encourages entrepreneurial activity among those with potential and
recognizes the contribution of people who inspire others with their
vision, leadership and achievement. As the first and only truly
global awards program of its kind, Entrepreneur Of The Year
celebrates those who are building and leading successful, growing
and dynamic businesses, recognizing them through regional, national
and global awards programs in more than 145 cities in more than 60
countries. ey.com/eoy
About EY
EY is a global leader in assurance, tax,
transaction and advisory services. The insights and quality
services we deliver help build trust and confidence in the capital
markets and in economies the world over. We develop outstanding
leaders who team to deliver on our promises to all of our
stakeholders. In so doing, we play a critical role in building a
better working world for our people, for our clients and for our
communities.
EY refers to the global organization and may refer to one or
more of the member firms of Ernst & Young Global Limited, each
of which is a separate legal entity. Ernst & Young Global
Limited, a UK company limited by guarantee, does not provide
services to clients. For more information about our organization,
please visit ey.com.
Media Contact at Regeneron:
Alexandra Bowie, Tel. 914.847.3407
alexandra.bowie@regeneron.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named-ey-2016-national-life-sciences-entrepreneurs-of-the-year-300366403.html
SOURCE Regeneron Pharmaceuticals, Inc.